Compare TECH & HLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TECH | HLI |
|---|---|---|
| Founded | 1976 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.1B | 9.6B |
| IPO Year | 1995 | 2015 |
| Metric | TECH | HLI |
|---|---|---|
| Price | $70.90 | $142.47 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 7 |
| Target Price | $71.82 | ★ $194.29 |
| AVG Volume (30 Days) | ★ 7.4M | 652.5K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | 0.62% | ★ 1.54% |
| EPS Growth | N/A | ★ 6.87 |
| EPS | 0.81 | ★ 6.22 |
| Revenue | $1,219,635,000.00 | ★ $2,617,516,000.00 |
| Revenue This Year | $2.49 | $13.77 |
| Revenue Next Year | $6.40 | $12.10 |
| P/E Ratio | $87.44 | ★ $22.53 |
| Revenue Growth | 5.23 | ★ 9.55 |
| 52 Week Low | $43.20 | $131.31 |
| 52 Week High | $72.16 | $211.78 |
| Indicator | TECH | HLI |
|---|---|---|
| Relative Strength Index (RSI) | 77.13 | 52.71 |
| Support Level | $55.97 | $134.84 |
| Resistance Level | $71.10 | $144.57 |
| Average True Range (ATR) | 1.48 | 4.08 |
| MACD | 1.24 | 0.64 |
| Stochastic Oscillator | 98.08 | 77.26 |
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Houlihan Lokey Inc is an investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments world-wide with offices in the United States, Europe, and the Asia-Pacific region. The company operates in three segments. In the Corporate Finance business segment, it provides M&A and capital markets advisory services. Through the Financial Restructuring business segment, the company advises on some of the complex restructurings around the world. The Financial and Valuation Advisory Services business segment provides valuation and financial opinion, and financial and strategic consulting practices in the United States.